{"acute respiratory failure": 2.6, "adrenal insufficiency": 2.37, "anaphylactic reaction": 4.12, "asthma": 37.84, "asthmatic crisis": 17.87, "blood immunoglobulin e increased": 11.31, "bronchitis": 3.16, "bronchospasm": 2.4, "chronic obstructive pulmonary disease": 2.51, "condition aggravated": 2.02, "cough": 2.29, "device defective": 14.19, "device delivery system issue": 14.46, "device issue": 3.38, "device leakage": 42.69, "device malfunction": 3.79, "device use issue": 21.78, "drug dose omission by device": 33.99, "drug ineffective": 2.18, "dysphonia": 2.68, "dyspnoea": 2.35, "eczema": 2.31, "eosinophil count abnormal": 162.78, "eosinophil count increased": 56.64, "eosinophilia": 3.54, "eosinophilic granulomatosis with polyangiitis": 51.43, "forced expiratory volume decreased": 16.86, "hypersensitivity": 2.32, "inappropriate schedule of product administration": 3.79, "incorrect dose administered by device": 12.66, "injection site haemorrhage": 3.21, "injection site rash": 3.26, "insurance issue": 19.21, "lower respiratory tract infection": 5.15, "lung disorder": 4.26, "middle insomnia": 3.3, "nasal congestion": 3.27, "nasal polyps": 113.78, "nasopharyngitis": 2.32, "needle issue": 5.83, "oxygen saturation decreased": 2.69, "pharyngitis": 6.89, "pneumonia": 2.22, "product distribution issue": 33.5, "product dose omission issue": 6.54, "productive cough": 3.97, "pulmonary function test decreased": 18.25, "rash pruritic": 2.12, "respiratory disorder": 2.02, "rhinitis": 3.39, "secretion discharge": 6.47, "sinusitis": 3.47, "therapeutic product effect decreased": 3.24, "therapeutic response shortened": 9.24, "throat tightness": 2.38, "urticaria": 2.59, "viral infection": 3.23, "wheezing": 9.18, "wrong technique in device usage process": 12.5}